2025-09-11 LabMCoP Meeting Notes

2025-09-11 LabMCoP Meeting Notes

Date

Sep 11, 2025

Attendees

Present

Name

Organization

Present

Name

Organization

X

Nancy Cornish

CDC

X

Manjula Dharmawardhana

CDC

X

Riki Merrick

APHL

X

Christina Gallegos

APHL

X

Amy Liu

Inductive Health / APHL

 

Raj Dash - regrets

Duke / CAP

 

John Snyder - regrets

 

 

Andrea Pitkus

UW

X

Kathy Walsh

Labcorp

 

Rob Hausam

Hausam Consulting

 

Pam Banning

 3M

Discussion topics

Upcoming OOO

 

Lab tests as procedures or orderables

not discussed

Definition from SNOMED for these hierarchies:

  • Observable entity: Information about a quality/property to be observed and how it will be observed

  • Evaluation procedure: No definition, other than it uses attributes that are similar to those used in the Observable entity hierarchy.  Our policy is to not add any new evaluation procedures that would logically be in the Observable entity hierarchy.

  • Technique is a separate hierarchy used to model observable entities: A technique (also called method) is a particular way of performing an activity or task.

Colonoscopy example:

Reference links:

clinical guidelines: Official journal of the American College of Gastroenterology | ACG

Quality Indicators: Official journal of the American College of Gastroenterology | ACG

Discussion:

Specimen CMT terms review

Christina

  • Serum - updated the comment to retain the note that we will add serum from donor

  • ToejointSynovialFluid - do we just want to have the more generic synovial fluid term? septic arthritis - we might have made all the pre-coordinated ones if they are common - the toejoint is related to gout

    • do we need to know which toe it was collected from (for testing maybe not, but it is always important to match what is in the clinical notes)

    • we may want to add the common uses for synovial fluid testing for each of the domain

  • VenousBlood_PulmonaryArteryCatheter_RightSubclavianVein - is one of many pre-coordinated terms, which we added to paovide the most common entry points, as they carry different risk of contamination

  • VenousBlood_tunnelCentralVounousCatheter - ok as is

  • VenousBlood_UmbilicalCatheter - ok as is

  • GanglionCyst_Excision - is the correct PHLIPPreferredName

    • when they collect the ganglionfluid tht is not usually sent to the lab

    • used to be called the bible-thumper lesion (cause that would burst the cyst)

FHIR conceptMap Follow Up

Riki

Specimen CMT draft profile on ConceptMap:

Added to the TI Agenda for Thursday Q1 (so Manjula will not be able to attend), but that’s what TI suggested

Call adjourned

 

11:55 AM ET - NEXT CALL September 25!

European Semantic work

not discussed

Link to the German FHIR IG around suceptibility testing:

https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fsimplifier.net%2Fguide%2Fars-implementation-guide%3Fversion%3Dcurrent&data=05%7C02%7Criki.merrick%40aphl.org%7Ce11e8daf7f2d4827d07808ddcac8861c%7C434e0aedef824568a0493b17adc08ddd%7C1%7C0%7C638889684844672822%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=kZJRoBl2tMQzWQoYVkaRnEUaaBxepA9sAIu1myDQMyo%3D&reserved=0

Semantic Example section: https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fsimplifier.net%2Fguide%2FARS-Implementation-Guide%2FHome%2FSemantics%3Fversion%3Dcurrent&data=05%7C02%7Criki.merrick%40aphl.org%7Ce11e8daf7f2d4827d07808ddcac8861c%7C434e0aedef824568a0493b17adc08ddd%7C1%7C0%7C638889684844702198%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=qQH%2Ff5xwG0O8DvNE4rbjZineXBhY%2BiOWmN047DRthNQ%3D&reserved=0

Creating Value Sets for specimen related attributes

not discussed

  • Specimen reject reason table review - review the “unsatisfactory for evaluation due to …” concepts

Previous Action Items

not discussed

Specimen CMT - Hosting Options

not discussed

  • How can we publish the content in the dB?

  • SNOMED CT Extension and use of RefSets (start with VSAC value sets as proof of concept and then migrate over) to indicate:

    • preferred specimen types by domain

    • maybe also terms that need additional attributes (by kind of attribute) if we also write an implementation guide for it

  • How do we decide what format to share this in - get input from EHR-s and LIS vendors:

    • Write letter of mulitple stakeholders to request EHR-s and LIS vendors to implement

      • indicating that this is a patient safety issue, as incorrect Abx treatment will contribute to multi-drug resistance (use CTSI findings to provide background)

      • focus on blood, urine, wound cultures (get data from NHSN, too)

    • Nancy is talking to DHQP about the linkage with specimen collection

    • While we have HIT certification that is for the EHR-s there is currently no enforcement for implementation at the organizations

    • need C-suite buy-in

    • Professional organizations - like CAP and ACOS and AJCC get them to write the synoptic reports (better structuring of data) - for surgical aspects - similar to what CAP has done for Cancer (though they do not have the SCT codes included in the past - may be including SNOMED CT starting in 2025, but they are also using the SCT codes for observables) https://www.facs.org/for-medical-professionals/news-publications/news-and-articles/bulletin/2021/12/synoptic-reporting-for-cancer-surgery-current-requirements-and-future-state/: The four CoC accreditation standards that include synoptic operative reporting requirements apply to sentinel lymph node biopsy for breast cancer (Standard 5.3), axillary lymph node dissection for breast cancer (Standard 5.4), wide local excision for primary cutaneous melanoma (Standard 5.5), and colonic resection for colon cancer (Standard 5.6). These accreditation standards were developed from the evidence-based recommendations for cancer surgery detailed in the Operative Standards for Cancer Surgery manuals.7,8

    • try to get AMA support to get providers to adopt this

    • Reach out to IDSA, too

Specimen CMT pilot implementers

not discussed

Specimen CMT - education

not discussed

  • Need education for providers and IT folks that helps with set up of the EHR-S / LIS configuration -this can be supported / accomplished? with the Implementaiton Guide we could write

  • if we have a use case of how a patient is impacted on their journey through the healthcare system - CAP created a nice video that showed how patient care was affected by incorrect data https://infobeta.cap.org/shield/

Specimen CMT - tracking implementation impact

  • Setting baseline

  • Define metrics

not discussed

 

Specimen CMT - Compare to NHS Medical Terminology testing

not discussed

 Will get updated vocab at a later date

Future projects for this call after CMT

not discussed

  • In general the call is intended as a forum for ANY messaging related issues to work out.

  • In the past we have

    • reviewed containers re-vive that - and how does that interact with devices (UDI identification?)

    • review code systems around additives (HL70371 and SCT substance and product hierarchies)

    • started work on cross-mapping between HL7 method codes and SNOMED CT procedure / technique concepts

      • American College of Surgeons is working on procedure protocol and synoptic data elements / surgical synoptic reports - we could work with them together on that

    • Look at other HL7 tables that we would want to migrate SCT (i.e., Specimen Condition table, etc.)

Recording:

did not record

Chat:

 

 

 

 

 

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.